The announcement regarding the launch of iNCOVACC on January 26 was made last week by the company’s chairman and managing director. The nasal Covid vaccination has already received official approval for use among people older than 18 years, and it will also be given as a heterologous booster dose.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/X7MEOWZ
via IFTTT
0 comments:
Post a Comment